...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Toxicity

Tada,

Wondering if any of BP involved in these Zenith Epigenetics clinical trials will take a leap to lock in this tech before there compeitors do i am sure those BP get a sneak peak at the data and know exactly what the ORR is in a few trials? 

 

 

Share
New Message
Please login to post a reply